MBX Biosciences, Inc. MBX
55.00 USD +0.60 (+1.10%)
At closeNov 3, 2026, 4:01 PM EST
55.00 0.00 0.00%
After hours · Nov 3, 4:01 PM ET
54.71 Day range 57.10
20.27 52-week range 72.64
- YTD
- +74.38%
- 1 year
- +166.86%
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 95.70 +74.0% upside
Now 55.00
- Target (low)
- 80.00
- Target (mean)
- 95.70
- Target (high)
- 150.00
Ratings (0m) 11 11 buy · 0 hold · 0 sell
- Strong buy3
- Buy8
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 11
- 1 month ago 11
- 2 months ago 12
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.84465 | -0.96 – -0.74 | -0.63 | -34.1% | 0 | 0.0% | 7 |
| Next quarter | -0.93098 | -1.29 – -0.82 | -0.49 | -90.0% | 0 | 0.0% | 7 |
| Current year | -3.05 | -3.30 – -2.91 | -2.38 | -28.3% | 0 | 0.0% | 8 |
| Next year | -3.98 | -4.50 – -3.64 | -3.05 | -30.2% | 0 | 0.0% | 8 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 12, 2026 | Stifel | Maintained | Buy | Buy |
| Oct 2, 2026 | Guggenheim | Maintained | Buy | Buy |
| Aug 10, 2026 | Truist Securities | Maintained | Buy | Buy |
| Jul 29, 2026 | Mizuho | Maintained | Outperform | Outperform |
| May 12, 2026 | Barclays | Maintained | Overweight | Overweight |
| May 12, 2026 | Citizens | Maintained | Market Outperform | Market Outperform |
| May 11, 2026 | Truist Securities | Maintained | Buy | Buy |
| Jan 28, 2026 | Barclays | Initiated | — | Overweight |
| Jan 16, 2026 | Guggenheim | Maintained | Buy | Buy |
| Jan 7, 2026 | UBS | Initiated | — | Buy |
| Dec 19, 2025 | Stifel | Maintained | Buy | Buy |
| Dec 4, 2025 | Goldman Sachs | Initiated | — | Sell |
| Nov 10, 2025 | Guggenheim | Maintained | Buy | Buy |
| Nov 4, 2025 | TD Cowen | Initiated | — | Buy |
| Oct 15, 2025 | Truist Securities | Initiated | — | Buy |
| Sep 24, 2025 | Mizuho | Maintained | Outperform | Outperform |
| Sep 23, 2025 | Oppenheimer | Maintained | Outperform | Outperform |
| Sep 23, 2025 | Guggenheim | Maintained | Buy | Buy |
| Aug 5, 2025 | Mizuho | Initiated | — | Outperform |
| Jul 16, 2025 | Oppenheimer | Initiated | — | Outperform |
| Apr 10, 2025 | JMP Securities | Initiated | — | Market Outperform |
| Apr 10, 2025 | Guggenheim | Reiterated | Buy | Buy |
| Oct 8, 2024 | Jefferies | Initiated | — | Buy |
| Oct 8, 2024 | JP Morgan | Initiated | — | Overweight |
| Oct 8, 2024 | Stifel | Initiated | — | Buy |
| Oct 8, 2024 | Guggenheim | Initiated | — | Buy |